Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT07440940

Timing of Subcostal TAPB Combined With Rectus Sheath Block for Postoperative Pain After Laparoscopic Cholecystectomy

Led by Eulji University Hospital · Updated on 2026-02-27

96

Participants Needed

1

Research Sites

46 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This prospective randomized controlled trial aims to evaluate whether the timing of ultrasound-guided subcostal transversus abdominis plane (TAP) block combined with rectus sheath block (RSB) affects postoperative pain in patients undergoing laparoscopic cholecystectomy. Participants will be randomly assigned to receive the combined regional blocks either before surgical incision or after completion of surgery. The primary outcome is postoperative pain intensity measured using a numerical rating scale. Secondary outcomes include opioid consumption, incidence of postoperative nausea and vomiting, and other recovery parameters. The results of this study may help optimize the timing of abdominal wall blocks to improve postoperative analgesia and recovery following laparoscopic cholecystectomy.

CONDITIONS

Official Title

Timing of Subcostal TAPB Combined With Rectus Sheath Block for Postoperative Pain After Laparoscopic Cholecystectomy

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 80 years
  • Scheduled for elective laparoscopic cholecystectomy
  • Ability to understand the study and provide informed consent
  • American Society of Anesthesiologists (ASA) physical status I to III
Not Eligible

You will not qualify if you...

  • Significant pain unrelated to the target disease interfering with pain assessment
  • Known allergy or contraindication to ropivacaine, acetaminophen, nefopam, or pethidine
  • Planned single-port laparoscopic cholecystectomy
  • American Society of Anesthesiologists (ASA) physical status IV or higher
  • Infection or anatomical abnormalities at the abdominal wall injection site
  • Major neurological, psychiatric, or systemic diseases affecting pain perception or study evaluation
  • Requirement for postoperative mechanical ventilation
  • Pregnancy or breastfeeding
  • Considered unsuitable by the investigator
  • Refusal or inability to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Nowon Eulji University Hospital

Seoul, South Korea, 01830

Actively Recruiting

Loading map...

Research Team

H

Hye-Yeon Cho, MD

CONTACT

S

Soojeong Kang, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here